Public health, innovation, intellectual property and trade

Public Hearing

Leading up to the first session of the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG), WHO held a web-based public hearing on 1-15 November to provide an opportunity to everyone, including the general public, to contribute to developing a solution to a major public health challenge — how to enhance innovation, research and development to address diseases predominantly affecting poor populations.

Contributions were sent in by individuals, civil society groups, government institutions, academic and research institutions, the private sector and other interested parties.

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



Contacts

Public health, innovation, intellectual property and trade
phidepartment@who.int

Dr Suzanne Hill
Director, EMP
Essential Medicines and Health Products (EMP)

Dr Marie-Paule Kieny
Assistant Director-General, HIS
Health Systems and Innovation (HIS)